Experienced in the healthcare and medical products field, Patrick Ridgeway concentrates on molecular testing and women’s health in his current position. Specifically, Patrick Ridgeway’s work advanced women’s healthcare through genetic testing for the screening of breast cancer.
Because women with a BRCA1 or BRCA2 mutation have a greatly increased risk of breast cancer, genetic testing proves a valuable tool in early detection. However, the test is recommended only for people with a high risk of the gene mutation, including those with a family member with BRCA1/2 or those with a personal history of breast cancer.
A genetic counselor is highly trained to advise on the potential benefits of the test. Benefits include the emotional relief that can come from a negative test, while a positive result can empower women and open other breast-cancer screening options and risk-reduction tools, such as prescription drugs and prophylactic mastectomy.
Comments
Post a Comment